Cannabis fails to slow progress of multiple sclerosis in UK study

LONDON (Reuters) – Cannabis capsules failed to slow the progression of multiple sclerosis in a large British study, dealing a blow to hopes that the drug could provide long-term benefits for patients with the debilitating nerve disease.